--- a +++ b/processing/MACCROBAT/28202869.ann @@ -0,0 +1,412 @@ +T1 Age 2 13 34-year-old +T2 Personal_background 14 22 Japanese +T3 Sex 23 28 woman +T4 Disease_disorder 48 52 MCTD +E1 Disease_disorder:T4 +#1 AnnotatorNotes E1 mixed connective tissue disease +T5 Disease_disorder 74 94 Raynaud's phenomenon +E2 Disease_disorder:T5 +T6 Sign_symptom 96 108 pancytopenia +E3 Sign_symptom:T6 +T7 Diagnostic_procedure 126 143 creatinine kinase +E4 Diagnostic_procedure:T7 +T8 Detailed_description 119 125 plasma +R1 MODIFY Arg1:T8 Arg2:E4 +T10 Diagnostic_procedure 168 188 U1-ribonucleoprotein +E5 Diagnostic_procedure:T10 +T12 Date 192 196 2005 +E6 Date:T12 +T13 Medication 219 231 prednisolone +E7 Medication:T13 +T14 Dosage 210 215 10 mg +T15 Dosage 232 237 daily +R4 MODIFY Arg1:T15 Arg2:E7 +R5 MODIFY Arg1:T14 Arg2:E7 +T9 Lab_value 110 118 elevated +E8 Lab_value:T9 +R2 MODIFY Arg1:E8 Arg2:E4 +T11 Lab_value 149 167 antibodies against +E9 Lab_value:T11 +R3 MODIFY Arg1:E9 Arg2:E5 +T16 Diagnostic_procedure 239 275 Pulmonary arterial systolic pressure +E10 Diagnostic_procedure:T16 +T18 Diagnostic_procedure 289 305 echocardiography +E11 Diagnostic_procedure:T18 +R7 SUB_PROCEDURE Arg1:E11 Arg2:E10 +T19 Lab_value 310 327 slightly elevated +E12 Lab_value:T19 +T20 Lab_value 329 336 48 mmHg +E13 Lab_value:T20 +R8 MODIFY Arg1:E12 Arg2:E10 +R9 MODIFY Arg1:E13 Arg2:E10 +T21 Date 341 345 2006 +E14 Date:T21 +T22 Sign_symptom 368 387 shortness of breath +E15 Sign_symptom:T22 +T23 Activity 391 406 physical effort +E16 Activity:T23 +T24 Detailed_description 356 367 progressive +R10 MODIFY Arg1:T24 Arg2:E15 +T25 Date 410 414 2011 +E17 Date:T25 +T28 Diagnostic_procedure 478 510 mean pulmonary arterial pressure +E19 Diagnostic_procedure:T28 +T26 Disease_disorder 416 447 Pulmonary arterial hypertension +E18 Disease_disorder:T26 +T27 Lab_value 467 474 74 mmHg +E20 Lab_value:T27 +T30 Diagnostic_procedure 512 516 mPAP +E21 Diagnostic_procedure:T30 +R12 IDENTICAL Arg1:E21 Arg2:E19 +R11 MODIFY Arg1:E20 Arg2:E19 +T29 Diagnostic_procedure 531 558 right heart catheterization +E22 Diagnostic_procedure:T29 +T31 Diagnostic_procedure 560 563 RHC +E23 Diagnostic_procedure:T31 +R14 IDENTICAL Arg1:E23 Arg2:E22 +T32 Date 568 572 2012 +E24 Date:T32 +T33 Medication 597 622 immunosuppressive therapy +E25 Medication:T33 +T34 Medication 574 590 Cyclophosphamide +E26 Medication:T34 +R15 SUB_PROCEDURE Arg1:E26 Arg2:E25 +A1 POLARITY E25 NEG +T35 Sign_symptom 674 693 menopausal symptoms +E27 Sign_symptom:T35 +A2 POLARITY E27 UNCERTAIN +T36 Detailed_description 668 673 early +R16 MODIFY Arg1:T36 Arg2:E27 +T37 Dosage 710 720 250 mg/day +T38 Medication 724 732 bosentan +E28 Medication:T38 +T39 Dosage 737 747 120 μg/day +T40 Medication 751 760 beraprost +E29 Medication:T40 +R17 MODIFY Arg1:T39 Arg2:E29 +R18 MODIFY Arg1:T37 Arg2:E28 +T41 Date 788 800 January 2014 +E30 Date:T41 +T42 Sign_symptom 806 813 dyspnea +E31 Sign_symptom:T42 +A3 TREND E31 INC +T43 Diagnostic_procedure 828 848 WHO functional class +E32 Diagnostic_procedure:T43 +T44 Lab_value 849 851 IV +E33 Lab_value:T44 +R19 MODIFY Arg1:E33 Arg2:E32 +T45 Clinical_event 866 874 admitted +E34 Clinical_event:T45 +T46 Nonbiological_location 882 890 hospital +R20 MODIFY Arg1:T46 Arg2:E34 +T47 Diagnostic_procedure 894 914 physical examination +E35 Diagnostic_procedure:T47 +T48 Diagnostic_procedure 926 949 systemic blood pressure +E36 Diagnostic_procedure:T48 +T49 Lab_value 922 925 low +E37 Lab_value:T49 +T50 Lab_value 951 961 89/61 mmHg +E38 Lab_value:T50 +R21 MODIFY Arg1:E38 Arg2:E36 +R22 MODIFY Arg1:E37 Arg2:E36 +T51 Sign_symptom 964 975 tachycardia +E39 Sign_symptom:T51 +T52 Lab_value 977 984 104/min +E40 Lab_value:T52 +R23 MODIFY Arg1:E40 Arg2:E39 +T53 Diagnostic_procedure 991 1009 blood oxygen level +E41 Diagnostic_procedure:T53 +T54 Lab_value 987 990 low +E42 Lab_value:T54 +R24 MODIFY Arg1:E42 Arg2:E41 +T55 Diagnostic_procedure 1011 1041 percutaneous oxygen saturation +E43 Diagnostic_procedure:T55 +R25 SUB_PROCEDURE Arg1:E43 Arg2:E41 +T56 Diagnostic_procedure 1043 1047 SpO2 +E44 Diagnostic_procedure:T56 +R26 IDENTICAL Arg1:E44 Arg2:E43 +T57 Lab_value 1049 1052 95% +E45 Lab_value:T57 +R27 MODIFY Arg1:E45 Arg2:E43 +T58 Sign_symptom 1070 1080 distension +E46 Sign_symptom:T58 +T59 Biological_structure 1055 1069 jugular venous +R28 MODIFY Arg1:T59 Arg2:E46 +T60 Sign_symptom 1102 1107 edema +E47 Sign_symptom:T60 +T61 Detailed_description 1093 1101 systemic +T62 Severity 1086 1092 severe +R29 MODIFY Arg1:T62 Arg2:E47 +R30 MODIFY Arg1:T61 Arg2:E47 +T63 Sign_symptom 1116 1124 crackles +E48 Sign_symptom:T63 +T64 Detailed_description 1109 1115 Coarse +R31 MODIFY Arg1:T64 Arg2:E48 +T65 Detailed_description 1129 1133 loud +T66 Sign_symptom 1134 1163 pulmonic valve closure sounds +E49 Sign_symptom:T66 +R32 MODIFY Arg1:T65 Arg2:E49 +T67 Diagnostic_procedure 1209 1227 6-minute walk test +E50 Diagnostic_procedure:T67 +A4 POLARITY E50 NEG +T68 Sign_symptom 1242 1249 dyspnea +E51 Sign_symptom:T68 +T69 Severity 1235 1241 severe +R33 MODIFY Arg1:T69 Arg2:E51 +T70 Diagnostic_procedure 1251 1274 Laboratory examinations +E52 Diagnostic_procedure:T70 +T71 Diagnostic_procedure 1298 1323 brain natriuretic peptide +E53 Diagnostic_procedure:T71 +T72 Detailed_description 1291 1297 plasma +R34 MODIFY Arg1:T72 Arg2:E53 +T73 Lab_value 1282 1290 elevated +E54 Lab_value:T73 +T74 Diagnostic_procedure 1325 1328 BNP +E55 Diagnostic_procedure:T74 +R35 IDENTICAL Arg1:E55 Arg2:E53 +R36 MODIFY Arg1:E54 Arg2:E53 +T75 Lab_value 1337 1348 929.4 pg/mL +E56 Lab_value:T75 +R37 MODIFY Arg1:E56 Arg2:E53 +T76 Sign_symptom 1351 1360 hypoxemia +E57 Sign_symptom:T76 +T77 Diagnostic_procedure 1362 1366 PaO2 +E58 Diagnostic_procedure:T77 +T78 Lab_value 1367 1376 62.5 mmHg +E59 Lab_value:T78 +R38 MODIFY Arg1:E59 Arg2:E58 +T79 Diagnostic_procedure 1378 1383 PaCO2 +E60 Diagnostic_procedure:T79 +T80 Lab_value 1384 1393 27.1 mmHg +E61 Lab_value:T80 +R39 SUB_PROCEDURE Arg1:E53 Arg2:E52 +R40 SUB_PROCEDURE Arg1:E58 Arg2:E52 +R41 SUB_PROCEDURE Arg1:E60 Arg2:E52 +R42 MODIFY Arg1:E61 Arg2:E60 +T81 Lab_value 1404 1434 presence of antibodies against +E62 Lab_value:T81 +T82 Diagnostic_procedure 1435 1455 U1-ribonucleoprotein +E63 Diagnostic_procedure:T82 +R43 MODIFY Arg1:E62 Arg2:E63 +T83 Lab_value 1457 1466 97.9 U/mL +E64 Lab_value:T83 +R44 MODIFY Arg1:E64 Arg2:E63 +R45 SUB_PROCEDURE Arg1:E63 Arg2:E52 +T84 Diagnostic_procedure 1479 1501 antinuclear antibodies +E65 Diagnostic_procedure:T84 +T85 Lab_value 1503 1508 1:640 +E66 Lab_value:T85 +T86 Lab_value 1510 1526 speckled pattern +E67 Lab_value:T86 +R46 MODIFY Arg1:E66 Arg2:E65 +R47 MODIFY Arg1:E67 Arg2:E65 +R48 SUB_PROCEDURE Arg1:E65 Arg2:E52 +T87 Diagnostic_procedure 1537 1542 X-ray +E68 Diagnostic_procedure:T87 +T88 Biological_structure 1531 1536 chest +R49 MODIFY Arg1:T88 Arg2:E68 +T89 Sign_symptom 1550 1558 enlarged +E69 Sign_symptom:T89 +T90 Biological_structure 1559 1577 pulmonary arteries +R50 MODIFY Arg1:T90 Arg2:E69 +T91 Sign_symptom 1582 1594 cardiomegaly +E70 Sign_symptom:T91 +T92 Diagnostic_procedure 1605 1622 Electrocardiogram +E71 Diagnostic_procedure:T92 +T93 Sign_symptom 1630 1646 P wave elevation +E72 Sign_symptom:T93 +T94 Detailed_description 1654 1665 V1-V2 leads +R51 MODIFY Arg1:T94 Arg2:E72 +T95 Diagnostic_procedure 1667 1670 RHC +E73 Diagnostic_procedure:T95 +T96 Diagnostic_procedure 1693 1697 mPAP +E74 Diagnostic_procedure:T96 +T97 Lab_value 1684 1692 elevated +E75 Lab_value:T97 +T98 Lab_value 1699 1706 65 mmHg +E76 Lab_value:T98 +R52 MODIFY Arg1:E75 Arg2:E74 +R53 MODIFY Arg1:E76 Arg2:E74 +T99 Diagnostic_procedure 1720 1753 pulmonary arterial wedge pressure +E77 Diagnostic_procedure:T99 +T17 Lab_value 1755 1762 12 mmHg +E78 Lab_value:T17 +T100 Lab_value 1713 1719 normal +E79 Lab_value:T100 +R6 MODIFY Arg1:E79 Arg2:E77 +R54 MODIFY Arg1:E78 Arg2:E77 +T101 Lab_value 1765 1769 high +E80 Lab_value:T101 +T102 Diagnostic_procedure 1770 1799 pulmonary vascular resistance +E81 Diagnostic_procedure:T102 +T103 Lab_value 1801 1820 1,547 dyne・sec・cm-5 +E82 Lab_value:T103 +R55 MODIFY Arg1:E82 Arg2:E81 +R56 MODIFY Arg1:E80 Arg2:E81 +T104 Lab_value 1827 1836 decreased +E83 Lab_value:T104 +T105 Diagnostic_procedure 1837 1851 cardiac output +E84 Diagnostic_procedure:T105 +T106 Lab_value 1853 1880 cardiac index 1.69 L/min/m2 +E85 Lab_value:T106 +R13 MODIFY Arg1:E85 Arg2:E84 +R57 MODIFY Arg1:E83 Arg2:E84 +T107 Diagnostic_procedure 1885 1911 ventilation/perfusion scan +E86 Diagnostic_procedure:T107 +T108 Disease_disorder 1931 1956 pulmonary thromboembolism +E87 Disease_disorder:T108 +A5 POLARITY E87 NEG +T109 Disease_disorder 1970 2007 chronic obstructive pulmonary disease +E88 Disease_disorder:T109 +A6 POLARITY E88 NEG +T110 Disease_disorder 2011 2037 interstitial lung diseases +E89 Disease_disorder:T110 +A7 POLARITY E89 NEG +T111 Diagnostic_procedure 2054 2073 computed tomography +E90 Diagnostic_procedure:T111 +T112 Sign_symptom 2079 2086 dyspnea +E91 Sign_symptom:T112 +T113 Disease_disorder 2141 2144 PAH +E92 Disease_disorder:T113 +#2 AnnotatorNotes E92 pulmonary arterial hypertension +T114 Disease_disorder 2125 2129 MCTD +E93 Disease_disorder:T114 +R58 CAUSE Arg1:E93 Arg2:E92 +R59 CAUSE Arg1:E92 Arg2:E91 +T115 Medication 2169 2177 bosentan +E94 Medication:T115 +T116 Medication 2182 2191 beraprost +E95 Medication:T116 +T117 Therapeutic_procedure 2216 2234 supportive therapy +E96 Therapeutic_procedure:T117 +T118 Therapeutic_procedure 2240 2262 oxygen supplementation +E97 Therapeutic_procedure:T118 +R60 SUB_PROCEDURE Arg1:E97 Arg2:E96 +T119 Medication 2267 2276 diuretics +E98 Medication:T119 +R61 SUB_PROCEDURE Arg1:E98 Arg2:E96 +T120 Dosage 2278 2287 40 mg/day +T121 Medication 2291 2301 furosemide +E99 Medication:T121 +R62 MODIFY Arg1:T120 Arg2:E99 +T122 Dosage 2318 2327 60 mg/day +T123 Medication 2331 2341 sildenafil +E100 Medication:T123 +R64 MODIFY Arg1:T122 Arg2:E100 +T124 Medication 2386 2395 beraprost +E101 Medication:T124 +T125 Dosage 2353 2382 gradual increment in the dose +R65 MODIFY Arg1:T125 Arg2:E101 +T126 Sign_symptom 2448 2455 dyspnea +E102 Sign_symptom:T126 +A8 TREND E102 STAY +T127 Diagnostic_procedure 2491 2494 BNP +E103 Diagnostic_procedure:T127 +T128 Detailed_description 2484 2490 plasma +R66 MODIFY Arg1:T128 Arg2:E103 +T129 Lab_value 2501 2510 increased +E104 Lab_value:T129 +R67 MODIFY Arg1:E104 Arg2:E103 +T130 Medication 2512 2516 IVCY +E105 Medication:T130 +#3 AnnotatorNotes E105 Intravenous cyclophosphamide +T131 Dosage 2518 2542 750 mg/m2, every 4 weeks +R68 MODIFY Arg1:T131 Arg2:E105 +T132 Medication 2575 2587 prednisolone +E106 Medication:T132 +T133 Dosage 2605 2616 60 mg daily +R69 MODIFY Arg1:T133 Arg2:E106 +T134 Sign_symptom 2622 2629 dyspnea +E107 Sign_symptom:T134 +A9 POLARITY E107 NEG +T135 Diagnostic_procedure 2683 2701 6-minute walk test +E108 Diagnostic_procedure:T135 +T136 Lab_value 2703 2708 260 m +E109 Lab_value:T136 +T137 Diagnostic_procedure 2710 2722 minimum SpO2 +E110 Diagnostic_procedure:T137 +T138 Lab_value 2723 2727 95 % +E111 Lab_value:T138 +R70 MODIFY Arg1:E109 Arg2:E108 +R71 MODIFY Arg1:E111 Arg2:E110 +T139 Diagnostic_procedure 2741 2744 BNP +E112 Diagnostic_procedure:T139 +T140 Detailed_description 2734 2740 plasma +R72 MODIFY Arg1:T140 Arg2:E112 +T141 Lab_value 2756 2765 decreased +E113 Lab_value:T141 +R73 MODIFY Arg1:E113 Arg2:E112 +T142 Medication 2790 2794 IVCY +E114 Medication:T142 +T143 Date 2805 2821 Six months after +E115 Date:T143 +T144 Clinical_event 2826 2835 admission +E116 Clinical_event:T144 +T145 Diagnostic_procedure 2849 2852 RHC +E117 Diagnostic_procedure:T145 +T146 Diagnostic_procedure 2871 2875 mPAP +E118 Diagnostic_procedure:T146 +T147 Lab_value 2862 2870 improved +E119 Lab_value:T147 +T148 Lab_value 2883 2890 53 mmHg +E120 Lab_value:T148 +R74 MODIFY Arg1:E120 Arg2:E118 +R75 MODIFY Arg1:E119 Arg2:E118 +T149 Diagnostic_procedure 2893 2922 pulmonary vascular resistance +E121 Diagnostic_procedure:T149 +R76 MODIFY Arg1:E119 Arg2:E121 +T150 Lab_value 2933 2952 1,116 dyne・sec・cm-5 +E122 Lab_value:T150 +R77 MODIFY Arg1:E122 Arg2:E121 +T151 Diagnostic_procedure 2959 2972 cardiac index +E123 Diagnostic_procedure:T151 +T152 Lab_value 2982 2995 1.83 L/min/m2 +E124 Lab_value:T152 +R78 MODIFY Arg1:E124 Arg2:E123 +R79 MODIFY Arg1:E119 Arg2:E123 +T153 Sign_symptom 3025 3031 stable +E125 Sign_symptom:T153 +T154 Date 3072 3087 18 months after +E126 Date:T154 +T155 Clinical_event 3092 3101 admission +E127 Clinical_event:T155 +T156 Medication 3134 3145 prostanoids +E128 Medication:T156 +A10 POLARITY E128 UNCERTAIN +T157 Administration 3123 3133 parenteral +R80 MODIFY Arg1:T157 Arg2:E128 +T158 Therapeutic_procedure 3149 3169 lung transplantation +E129 Therapeutic_procedure:T158 +A11 POLARITY E129 UNCERTAIN +* OVERLAP E1 E2 E3 E4 E5 E6 +R81 BEFORE Arg1:E6 Arg2:E7 +R82 BEFORE Arg1:E7 Arg2:E10 +* OVERLAP E10 E14 +R83 BEFORE Arg1:E14 Arg2:E15 +R84 CAUSE Arg1:E16 Arg2:E15 +* OVERLAP E15 E16 E17 +R85 BEFORE Arg1:E17 Arg2:E18 +* OVERLAP E18 E19 E22 E24 E26 E27 +R86 BEFORE Arg1:E27 Arg2:E28 +* OVERLAP E28 E29 +R87 BEFORE Arg1:E29 Arg2:E30 +* OVERLAP E30 E31 E32 E34 E35 E36 E39 E41 E46 E47 E48 E49 E50 E51 E52 E57 E68 E69 E70 E71 E72 E73 E74 E77 E81 E84 E86 E87 E88 E89 E90 E91 E93 E92 E94 E95 +R88 BEFORE Arg1:E95 Arg2:E96 +R63 SUB_PROCEDURE Arg1:E99 Arg2:E98 +* OVERLAP E96 E100 E101 +R89 BEFORE Arg1:E101 Arg2:E102 +* OVERLAP E102 E103 +R90 BEFORE Arg1:E103 Arg2:E105 +* OVERLAP E105 E106 +R91 BEFORE Arg1:E106 Arg2:E107 +* OVERLAP E107 E108 E110 E112 +R92 AFTER Arg1:E112 Arg2:E114 +R93 BEFORE Arg1:E114 Arg2:E115 +R94 AFTER Arg1:E115 Arg2:E116 +R95 BEFORE Arg1:E116 Arg2:E117 +* OVERLAP E117 E118 E121 E123 +R96 BEFORE Arg1:E123 Arg2:E125 +* OVERLAP E125 E126 +R97 AFTER Arg1:E126 Arg2:E127 +R98 BEFORE Arg1:E127 Arg2:E128 +* OVERLAP E128 E129